CIK: 1770790 - Address: C/O Quince Therapeutics, Inc., 611 Gateway Blvd., Suite 273, South San Francisco, CA 94080
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

12/14/23 18:21
12/12/23
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagLamond DavidCADP.m691.0206816,686M
12/7/23 18:30
12/5/23
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagLamond DavidCADP.m581.0105714,316I
12/1/23 13:38
11/29/23
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagLamond DavidCADP.m410.940004314,259I
8/31/23 18:42
8/30/23
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagLamond DavidCADP.m1081.3208224,216I
8/17/23 18:08
8/15/23
QNCXQuince Therapeutics, Inc.CAHealthBioPrdBiological Products, (No DiagLamond DavidCADP.m3261.30025064,134I
5/23/22 18:18
5/20/22
AMTIApplied Molecular Transport Inc.DEHealthDrugPharmaceutical PreparationsLamond DavidCADP.m2113.1706771,078I
4/7/21 18:47
4/6/21
AMTIApplied Molecular Transport Inc.DEHealthDrugPharmaceutical PreparationsLamond DavidCADP1,05042.0002531,011I
3/24/21 21:06
3/24/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLamond DavidCADP1,68933.7705013,684I
3/5/21 17:54
3/4/21
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLamond DavidCADP1,76735.3405022,099I
6/8/20 18:47
6/4/20
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLamond DavidCADP2,12643.2704922,049I
5/19/20 18:41
5/15/20
CRTXCortexyme, Inc.DEHealthBioPrdBiological Products, (No DiagLamond DavidCADP.m2,47155.3504522,000I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact